Cachet(SZ:002462) Xin Lang Cai Jing·2025-11-20 03:51Core Viewpoint - The stock of Jia Shitang has shown a mixed performance in recent trading sessions, with a year-to-date increase of 19.45% but a slight decline in the last five days, indicating potential volatility in investor sentiment [1][2]. Group 1: Stock Performance - On November 20, Jia Shitang's stock rose by 2.01%, reaching 15.23 CNY per share, with a trading volume of 63.68 million CNY and a turnover rate of 1.46%, resulting in a total market capitalization of 4.443 billion CNY [1]. - Year-to-date, Jia Shitang's stock has increased by 19.45%, with a 1.10% decline over the last five trading days, a 7.78% increase over the last 20 days, and a 4.75% increase over the last 60 days [1]. - The company has appeared on the "Dragon and Tiger List" once this year, with the most recent occurrence on May 8, where it recorded a net buy of -534.52 million CNY [1]. Group 2: Financial Performance - For the period from January to September 2025, Jia Shitang reported operating revenue of 14.459 billion CNY, a year-on-year decrease of 21.80%, and a net profit attributable to shareholders of 141 million CNY, down 38.81% year-on-year [2]. - Since its A-share listing, Jia Shitang has distributed a total of 874 million CNY in dividends, with 216 million CNY distributed over the past three years [3]. Group 3: Shareholder Information - As of September 30, Jia Shitang had 22,700 shareholders, an increase of 3.39% from the previous period, with an average of 12,814 circulating shares per shareholder, a decrease of 3.28% [2]. Group 4: Industry Classification - Jia Shitang is classified under the Shenwan industry as part of the pharmaceutical and biological sector, specifically in pharmaceutical commerce and distribution, with involvement in various concept sectors including small-cap stocks, pharmaceutical e-commerce, cold chain logistics, and medical devices [2].